Product Images Nityr

NITYR® is a tablet containing nitisinone used for oral consumption. It is manufactured by PCI Pharma Services in the UK and marketed by Cycle Pharmaceuticals Ltd. The tablets should be kept in a tight, light-resistant container and stored at a temperature between 20°C to 25°C. The prescription drug should be kept out of reach and sight of children. Dosage and usage instructions can be found in the prescribing information. Lot number and expiry date are available but not provided in the text.*

NITYR® (nitisinone) is a medication in tablet form for oral use, marketed by Cycle Pharmaceuticals Ltd based in Cambridge, UK. It is manufactured by PCl Pharma Services in Tredegar, UK. The medication should be dispensed in a tight and light-resistant container as defined in USP, and kept at a temperature range of 20°C to 25°C (68°F to 77°F). The tablets come in a bottle of 60 tablets and the NDC number is 70709-002-60. Dosage and use should be determined based on the prescribing information provided. The lot number and expiration date are both provided. The medication should be kept out of the reach and sight of children.*

Cycle Pharmaceuticals Ltd markets this product, which is manufactured by PCl Pharma Services. It is recommended to store the drug in a tight and light-resistant container and at room temperature. The NDC number for this product is 70709-005-60, and it is to be used orally. Dosage and usage information can be found in the prescribing information. Keep this drug out of the reach and sight of children. A lot number is provided.*

This is a description of a medication called NITYR. It is marketed by Cycle Pharmaceuticals Ltd in the UK and is manufactured by PClI Pharma Services. The medication is in tablet form and each tablet contains 10mg of Nitisinone, along with inactive ingredients such as glyceryl dibehenate and lactose monohydrate. NITYR should be stored at room temperature and kept in a tightly sealed container. It is only available with a prescription and should be kept out of reach of children. For more information, refer to the prescribing information or contact Cycle Pharmaceuticals Ltd.*

This is a medication information sheet for oge o tablets, containing nitisinone 2mg, marketed by Cycle Pharmaceuticals Ltd. The sheet provides dosage instructions and contact information for questions or concerns. It also includes details about the inactive ingredients and storage instructions.*

This is a medication for oral use containing Nitisinone 5 mg. It is manufactured by PCI Pharma Services, Tredegar, NP22 3AA, UK and marketed by Cycle Pharmaceuticals Ltd, Cambridge, CB3 OFA, UK. The tablets come in a container that is tight and light-resistant and must be kept out of reach and sight of children. The medication can be stored at room temperature, and for dosage and use, one should refer to the prescribing information. For any questions or concerns contact Cycle Pharmaceuticals Ltd at 1-855-831-5413. NDC 70709-005-60.*